Physician profile
Farn Huei Chan
NPI 1417164476
$29,361.31
in general payments reported to CMS, 2019-2025
95 companies · $5,211 in 2025
The $5,211 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,006 · 2020: $4,670 · 2021: $2,594 · 2022: $3,441 · 2023: $4,645 · 2024: $4,794 · 2025: $5,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $17.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,632.83 |
| Education | $17.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,909.38 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Abbvie INC. | $2,207.13 | 2019-2025 | Venclexta |
| Novartis Pharmaceuticals Corporation | $1,746.05 | 2019-2025 | |
| Pfizer INC. | $1,471.20 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,392.97 | 2019-2025 | Calquence, Lynparza, Imfinzi |
| Celgene Corporation | $1,056.63 | 2019-2025 | Breyanzi, Reblozyl, Opdualag |
| Merck Sharp & Dohme LLC | $936.40 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $930.91 | 2019-2025 | Opdivo |
| Genentech USA, INC. | $889.68 | 2019-2025 | Lunsumio, Polivy, Tecentriq |
| Genzyme Corporation | $738.01 | 2019-2025 | |
| Seagen INC. | $691.85 | 2019-2023 | Tukysa, Adcetris, Tivdak |
| Takeda Pharmaceuticals U.S.A., INC. | $659.88 | 2019-2025 | Iclusig, Fruzaqla, Alunbrig |
| Tersera Therapeutics LLC | $585.90 | 2020-2025 | Xermelo, Zoladex, Quzyttir |
| Incyte Corporation | $540.95 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Eisai INC. | $538.41 | 2019-2025 |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $529.33 | 2019-2023 | Imbruvica |
| Daiichi Sankyo INC. | $518.28 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Exelixis INC. | $513.43 | 2019-2025 | Cabometyx |
| Amgen INC. | $458.88 | 2019-2023 | Lumakras, Kyprolis, Blincyto |
| Astellas Pharma US INC | $423.35 | 2019-2025 | Padcev, Xospata, Vyloy |
| Taiho Oncology, INC. | $415.11 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $396.07 | 2019-2024 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $345.30 | 2019-2025 | Libtayo, Lynozyfic |
| Lilly USA, LLC | $328.85 | 2019-2021 | |
| Array Biopharma INC | $312.73 | 2019-2025 | Braftovi, Lorbrena, Mektovi |
| Alexion Pharmaceuticals, INC. | $311.59 | 2019-2025 | Ultomiris |
| Karyopharm Therapeutics INC. | $311.15 | 2020-2025 | Xpovio |
| Bayer Healthcare Pharmaceuticals INC. | $294.37 | 2019-2025 | |
| Kite Pharma, INC. | $274.59 | 2020-2025 | Yescarta |
| Servier Pharmaceuticals LLC | $273.17 | 2022-2025 | |
| Emd Serono, INC. | $258.73 | 2019-2025 | Tepmetko |
| Beigene USA, INC. | $254.85 | 2020-2025 | Brukinsa, Tevimbra |
| Glaxosmithkline, LLC. | $250.53 | 2023-2025 | Ojjaara, Jemperli, Zejula |
| Puma Biotechnology, INC. | $249.94 | 2019-2025 | |
| Gilead Sciences, INC. | $248.21 | 2019-2025 | Trodelvy |
| Genmab U.S., INC. | $232.13 | 2023-2025 | Epkinly |
| Ipsen Biopharmaceuticals, INC | $231.37 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Beone Medicines USA, INC. | $204.16 | 2025 | Brukinsa, Tevimbra |
| Deciphera Pharmaceuticals INC. | $199.58 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Global Blood Therapeutics, INC. | $194.45 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $194.29 | 2022-2025 | Monoferric |
| Sobi, INC | $179.52 | 2022-2025 | |
| Blueprint Medicines Corporation | $171.62 | 2021-2024 | Ayvakit |
| Aveo Pharmaceuticals, INC. | $166.31 | 2021-2024 | Fotivda |
| Rigel Pharmaceuticals, INC. | $165.48 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Acrotech Biopharma INC. | $154.00 | 2023-2025 | Beleodaq |
| Foundation Medicine, INC. | $150.40 | 2019-2023 | |
| Coherus Oncology, INC. | $145.77 | 2021-2025 | Udenyca, Loqtorzi |
| Alnylam Pharmaceuticals INC. | $134.70 | 2023-2025 | Givlaari |
| Agios Pharmaceuticals, INC. | $118.35 | 2023-2025 | Pyrukynd |
| Mirati Therapeutics, INC. | $115.98 | 2023 | Krazati |
| Adc Therapeutics America, INC. | $111.59 | 2022-2025 | |
| Tg Therapeutics, INC. | $109.02 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.61 | 2019-2025 | |
| Pharmaessentia USA Corporation | $91.62 | 2024-2025 | Besremi |
| Adaptive Biotechnologies Corporation | $89.84 | 2024-2025 | Clonoseq |
| Spectrum Pharmaceuticals INC. | $86.41 | 2023-2025 | Rolvedon |
| Jazz Pharmaceuticals INC. | $86.22 | 2019-2020 | |
| Caris Mpi, INC. | $83.86 | 2025 | Mi Cancer Seek |
| Sun Pharmaceutical Industries INC. | $82.71 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $81.69 | 2019 | |
| Stemline Therapeutics INC. | $78.09 | 2023-2025 | Orserdu, Elzonris |
| Morphosys, US INC. | $76.44 | 2021-2023 | Monjuvi |
| Epizyme, INC. | $75.00 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $72.42 | 2022-2024 | Myrisk |
| Eusa Pharma (US) LLC | $70.85 | 2020-2022 | |
| Novocure INC. | $69.95 | 2024-2025 | Optune, Optune Lua (Novottf-200t) |
| Menarini Silicon Biosystems, INC. | $69.19 | 2025 | |
| Accord Healthcare, INC. | $68.55 | 2025 | |
| Heron Therapeutics, INC. | $62.85 | 2019-2023 | Cinvanti |
| Azurity Pharmaceuticals, INC. | $57.92 | 2024-2025 | Danziten, Vivimusta |
| Clovis Oncology, INC. | $55.35 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $47.75 | 2023-2024 | Empaveli |
| G1 Therapeutics, INC. | $46.06 | 2022 | |
| Fennec Pharmaceuticals, INC. | $45.89 | 2025 | Fyarro |
| Amneal Pharmaceuticals LLC | $44.95 | 2024 | Avastin |
| Acceleron Pharma, INC. | $40.42 | 2020-2021 | |
| Partner Therapeutics, INC. | $39.42 | 2019 | |
| Syndax Pharmaceuticals, INC. | $32.51 | 2025 | |
| Recordati_rare_diseases_inc. | $31.62 | 2025 | Sylvant |
| Secura Bio, INC. | $31.00 | 2020-2024 | Copiktra |
| Cumberland Pharmaceuticals, INC. | $26.87 | 2024 | Sancuso |
| Tempus Ai, INC | $25.97 | 2024 | Xt Cdx |
| Biocon Biologics INC | $24.15 | 2025 | Ogivri |
| Kyowa Kirin, INC. | $24.13 | 2023 | Poteligeo |
| Tesaro, INC. | $23.37 | 2019 | |
| Ge Healthcare | $22.76 | 2022 | |
| Amag Pharmaceuticals, INC. | $20.91 | 2021 | |
| Immunocore Limited | $20.27 | 2024 | Kimmtrak |
| Cycle Pharmaceuticals INC | $20.00 | 2025 | Phyrago |
| Celltrion USA INC. | $18.92 | 2023 | Vegzelma |
| Organon LLC | $17.52 | 2021 | |
| Invivyd INC | $16.60 | 2025 | Pemgarda |
| Helsinn Therapeutics (U.S.), INC. | $16.53 | 2019 | |
| Mylan Institutional INC. | $14.59 | 2023 | Fulphila, Ogivri |
Drugs and devices associated with these payments
Kisqali $523Tecvayli $511Epkinly $492Darzalex $432Imbruvica $397Cabometyx $294Lenvima $275Talvey $256Padcev $255Keytruda $242Calquence $241Jakafi $223Adcetris $220Sarclisa $218Rybrevant $218Enhertu $218Lonsurf $209Inqovi $209Brukinsa $206Elrexfio $203Tibsovo $202Monjuvi $201Erleada $196Braftovi $193Libtayo $189Xermelo $189Ibrance $186Tukysa $185Xpovio $184Iclusig $183Carvykti $179Zoladex $178Ultomiris $176Opdivo $175Lorbrena $173Mektovi $172Qinlock $167Rezlidhia $165Tavalisse $165Monoferric $165Xarelto $162Inlyta $162Lunsumio $161Pluvicto $159Polivy $158Bosulif $158Beleodaq $154Lutathera $151Breyanzi $150Tevimbra $140Yescarta $137Givlaari $135Ojjaara $133Tecentriq $133Lynparza $125Trodelvy $123Pyrukynd $118Krazati $116Somatuline Depot $115Onivyde $115Fabhalta $115Ayvakit $111Xtandi $111Vonjo $108Columvi $107Udenyca $106Jevtana $105Reblozyl $99.32Jemperli $97.01Besremi $91.62Clonoseq $89.84Rolvedon $86.41Opdualag $86.40Mi Cancer Seek $83.86Talzenna $83.08Stivarga $78.06Vitrakvi $78.06Nubeqa $77.96Zynyz $75.45Zejula $74.19Pomalyst $69.38Cellsearch $69.19Camcevi $68.55Idhifa $66.92Imfinzi $63.29Pemazyre $62.63Orserdu $62.52Promacta $61.70Elahere $60.68Akeega $60.58Fotivda $60.52Oxbryta $59.29Fruzaqla $58.09Optune $53.36Besponsa $51.57Tivdak $50.97Alunbrig $50.63Tazverik $49.70Lumakras $49.29Keytruda Qlex $48.42
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farn Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.